NCT01682135View on ClinicalTrials.gov

A Study in Participants With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Solid Tumor
Interventions
BIOLOGICAL

Ramucirumab

Administered IV.

Trial Locations (1)

200032

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Shanghai

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01682135 - A Study in Participants With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter